l carnitine in ckd heart pubmed The Role of L-Carnitine Kidney Disease and Related Metabolic Dysfunctions Safety and efficacy of L-carnitine – New Product Launch - RenalGuard

Methods Eligibility criteria The PICOS strategy was defined as follows: P (participants) human subjects, I (interventions) oral LC treatment, C (comparisons) between supplementation and placebo, supplementation and control, or pre- and post- supplementation, O (outcomes) muscle variables, and S (study design) randomized controlled trials, non-randomized controlled trials, non-randomized non-controlled trials

(1200 ) 4 : 200 , , 600

It's also linked to better circulation, more energy, and even heart support

4.- Benjamin T

Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting